Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Marijuana Legalization: The Next “Domino” May Be About to Fall

By InvestorPlace Research Staff
Summertime is downtime for a lot of occupations – and politics is no exception. But that’s not to say there are no new developments. For example…right now, a movement is quietly gathering steam in one southeastern state, and it’s not getting much attention in the usual media outlets.

10 Marijuana Stocks That Could See 100% Gains, If Not More

By James Brumley, InvestorPlace Feature Writer
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.

Watch Cronos Stock Continue to Grow Over the Coming Weeks

By David Moadel, InvestorPlace Contributor
The cannabis sector is poised to break out of the summer doldrums -- and CRON stock will lead the charge.

Major Headlines Mean Opportunities for Smart Investors

By InvestorPlace Research Staff
Last week was full of major headlines, Matt McCall takes a look.

Aurora Cannabis Shareholders Aren’t Happy

By Mark Putrino, CMT
Aurora Cannabis share holders are not happy and they shouldn't be. A big part of the value of the company may be an illusion.

7 Marijuana Penny Stocks That I May Buy

By Mark Putrino, CMT
Most companies that have stocks that trade for pennies are doomed. These seven marijuana companies are penny stocks, but they may survive.

Canopy Growth Stock Is Not the Place for Near-Term Cannabis Refuge

By Todd Shriber, InvestorPlace Contributor
Shares of Canopy Growth stock are battered and the company's path to profitability may take too long for some investors' liking.

Hexo Stock Needs Just Two Things to Move Higher

By Will Healy, InvestorPlace Contributor
Hexo stock lies below the top tier in its industry, but it offers a solid home base and a partnership that may eventually take it higher.

Hexo’s Burn Rate Is Dangerously High

By Mark R. Hake, CFA
Hexo's acquisition of Newstrike is continuosly bleeding money, meaning HEXO stock will falter unless investors see clear signs of a turnaround.

Marijuana Stocks: Catch the Next Hot Pot Stock Before It ‘Jumps’

By InvestorPlace Research Staff
As legalization gets closer, the trickle of marijuana stocks uplisting to major exchanges could turn into a flood. And you can make a heck of a lot of money investing in the best pot stocks BEFORE they “jump.”

All Eyes Are on Canopy Growth’s Revenue

By Mark R. Hake, CFA
Canopy Growth (CGC) stock reports earnings after the bell. Can its numbers back up the ambition goal of its CEO to reach $1 billion in sales?

3 Reasons to Love Cronos Stock

By Wayne Duggan, InvestorPlace Contributor
CRON stock is not without its risks. But recent bullish commentary from Piper Jaffray highlights all the reasons long-term investors may need to take a closer look at Cronos.

An Unlikely Victim of the Cannabis Craze

By InvestorPlace Research Staff
From marijuana to sports betting to autonomous vehicles, here's the latest on the trends that can make you life-changing gains.

If You Like Hexo stock, This May Be A Good Time To Buy It

By Mark Putrino, CMT
If you like HEXO stock, it may be time to look at getting in. After being oversold, it recently found support around the $4 level.

Don’t Mess With Canopy Growth Stock Until CGC Reports Earnings

By Chris Tyler, InvestorPlace Contributor
Given the increased risks for bulls and bears, we can expect CGC stock to present a stronger trade after the earnings reaction, not before.

Molson Coors May Be the Only Thing Propping Up HEXO Stock

By Will Ashworth, InvestorPlace Contributor
As I stated in July, the Truss partnership with Hexo is ready to go when the legalization of cannabis-infused drinks happens in October, and distribution rolls out in December after the required 60-day waiting period.

4 Reasons to Buy Hexo Stock Despite the Rough Ride

By Theodore Kim
Hexo stocks hasn't had the best luck lately, but interested investors might be wise to view this as a buying opportunity.

6 Catalysts That Say National Marijuana Legalization Is Nigh

By InvestorPlace Research Staff
Matt McCall walks us through the ENORMOUS implications for marijuana investors as the road to marijuana legalization gets shorter and shorter.

Canopy Growth Stock Is a Buy Near $32

By Nicolas Chahine, InvestorPlace Contributor
While the current valuation for CGC is insane, Canopy Growth stock will grow into it with time, making it a promising long-term play.
Load More